New Key Statistics Module, Z-Score and F-Score
OTCPK:JCRRF Key Ratios
| Market Cap $ M | 562.36 |
| Enterprise Value $ M | 669.04 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | 19.96 |
| Price/Book | 1.59 |
| Price/Sales | 2.56 |
| Price/Free Cash Flow | 12.51 |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 237.00 |
| EPS (TTM) $ | -0.03 |
| Beneish M-Score | -2.43 |
| 10-y EBITDA Growth Rate % | 16.40 |
| 5-y EBITDA Growth Rate % | 13.60 |
| y-y EBITDA Growth Rate % | -87.80 |
| EV-to-EBIT | -311.14 |
| EV-to-EBITDA | 74.78 |
| PEG | -- |
| Shares Outstanding M | 125.50 |
| Net Margin (%) | -1.24 |
| Operating Margin % | -0.58 |
| Pre-tax Margin (%) | -1.23 |
| Quick Ratio | 0.98 |
| Current Ratio | 1.65 |
| ROA % (ttm) | -0.42 |
| ROE % (ttm) | -0.78 |
| ROIC % (ttm) | -0.23 |
| Dividend Yield % | 2.82 |
| Altman Z-Score | 2.21 |
JCRRF Number of Guru Trades
JCRRF Volume of Guru Trades
Gurus Latest Trades with OTCPK:JCRRF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:JCRRF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
JCR Pharmaceuticals Co Ltd Insider Transactions
No Available Data
News about OTCPK:JCRRF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers